MULTIMEDIA UPDATE – Albireo Announces FDA Approval of Bylvay™ (odevixibat), the First Drug Treatment for Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)
Bylvay(TM) (odevixibat) – Product Photo Bylvay(TM) is a once-daily drug indicated for the treatment of…
HiBob Named Best HR Management Software in the UK for 2026
Ionik Announces 30-Day Extension of Senior Debt Facility
NTG Clarity to Announce First Quarter Financial Results on May 27, 2026 with Earnings Call to Follow
Voghion Expands Beyond Fashion to Build a One-Stop Lifestyle Platform Across Europe